Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DPY19L2P2 |
| Upstream (Parents) |
|---|
| (<<) FMO4 → DPY19L2P2 |
| (<<) SLC25A20 → DPY19L2P2 |
| (<<) HPN → DPY19L2P2 |
| (<<) SDS → DPY19L2P2 |
| (<<) SLC17A4 → DPY19L2P2 |
| Downstream (Children) |
|---|
| DPY19L2P2 → MBD6 (>>) |
| DPY19L2P2 → DNTT (>>) |
| DPY19L2P2 → HRASLS (>>) |
| DPY19L2P2 → GPR22 (>>) |
| DPY19L2P2 → PP14571 (>>) |
| DPY19L2P2 → LPO (>>) |
| DPY19L2P2 → ERBB4 (>>) |
| DPY19L2P2 → ARSF (>>) |
| DPY19L2P2 → MAPK4 (>>) |
| DPY19L2P2 → FOXD3 (>>) |
